| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $771,336.15 | $771,336.15 | $771,336.15 | |
Kaiser Permanente
| Professional | $613,049.73 | $668,781.52 | $780,245.11 |
Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $771,336.15 | $771,336.15 | $771,336.15 | |
Kaiser Permanente
| Professional | $613,049.73 | $668,781.52 | $780,245.11 |